TD Asset Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
CIP
FAM
FLAM
TD Asset Management's ATRC Position: Q1 2023 in Review
TD Asset Management sold out of AtriCure (ATRC) in Q1 2023, closing a stake of 34,766 shares — an estimated $1.54M sold.
TD Asset Management first reported a position in ATRC in Q1 2018 and held it in 20 quarters. The position peaked at $5.54M in Q4 2021. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.
- TD Asset Management reported no remaining AtriCure position as of Q1 2023 after selling out during the quarter.
- TD Asset Management sold 34,766 AtriCure shares in Q1 2023, an estimated $1.54M.
- TD Asset Management first reported a position in AtriCure in Q1 2018 and held it in 20 quarters.
- TD Asset Management's AtriCure position peaked at $5.54M in Q4 2021.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.